Literature DB >> 17575303

Searching for unique endophenotypes for schizophrenia and bipolar disorder within neural circuits and their molecular regulatory mechanisms.

Francine M Benes1.   

Abstract

The endophenotype is a construct that has utility for the study of postmortem brains from patients with psychotic disorders. By identifying networks of genes that show changes in expression within specific neuronal populations implicated in the pathophysiology of schizophrenia and bipolar disorder, it may be possible to move toward understanding these disorders at the cellular and molecular levels. The ultimate goal is to characterize their respective underlying genotypes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17575303      PMCID: PMC2632324          DOI: 10.1093/schbul/sbm064

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  31 in total

Review 1.  Emotion circuits in the brain.

Authors:  J E LeDoux
Journal:  Annu Rev Neurosci       Date:  2000       Impact factor: 12.449

2.  Amygdala, hippocampus and discriminative fear conditioning to context.

Authors:  E A Antoniadis; R J McDonald
Journal:  Behav Brain Res       Date:  2000-02       Impact factor: 3.332

3.  Amygdalar activation alters the hippocampal GABA system: "partial" modelling for postmortem changes in schizophrenia.

Authors:  S Berretta; D W Munno; F M Benes
Journal:  J Comp Neurol       Date:  2001-03-05       Impact factor: 3.215

Review 4.  The endophenotype concept in psychiatry: etymology and strategic intentions.

Authors:  Irving I Gottesman; Todd D Gould
Journal:  Am J Psychiatry       Date:  2003-04       Impact factor: 18.112

Review 5.  Amygdalo-entorhinal inputs to the hippocampal formation in relation to schizophrenia.

Authors:  F M Benes; S Berretta
Journal:  Ann N Y Acad Sci       Date:  2000-06       Impact factor: 5.691

6.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study.

Authors:  A Guidotti; J Auta; J M Davis; V Di-Giorgi-Gerevini; Y Dwivedi; D R Grayson; F Impagnatiello; G Pandey; C Pesold; R Sharma; D Uzunov; E Costa; V DiGiorgi Gerevini
Journal:  Arch Gen Psychiatry       Date:  2000-11

7.  Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non-desensitizing AMPA receptors in hippocampal cultures.

Authors:  A Cristina Rego; Nuno M Monteiro; Ana P Silva; Joana Gil; João O Malva; Catarina R Oliveira
Journal:  J Neurochem       Date:  2003-08       Impact factor: 5.372

Review 8.  Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.

Authors:  Xiaohua Li; Gautam N Bijur; Richard S Jope
Journal:  Bipolar Disord       Date:  2002-04       Impact factor: 6.744

9.  DNA fragmentation decreased in schizophrenia but not bipolar disorder.

Authors:  Francine M Benes; John Walsh; Sujoy Bhattacharyya; Archna Sheth; Sabina Berretta
Journal:  Arch Gen Psychiatry       Date:  2003-04

10.  DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia.

Authors:  Ned Buttner; Sujoy Bhattacharyya; John Walsh; Francine M Benes
Journal:  Schizophr Res       Date:  2007-04-17       Impact factor: 4.939

View more
  21 in total

Review 1.  Animal models of bipolar mania: The past, present and future.

Authors:  R W Logan; C A McClung
Journal:  Neuroscience       Date:  2015-08-24       Impact factor: 3.590

Review 2.  Acetyltransferases (HATs) as targets for neurological therapeutics.

Authors:  Anne Schneider; Snehajyoti Chatterjee; Olivier Bousiges; B Ruthrotha Selvi; Amrutha Swaminathan; Raphaelle Cassel; Frédéric Blanc; Tapas K Kundu; Anne-Laurence Boutillier
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

3.  Test-retest reliability of amygdala response to emotional faces.

Authors:  Colin L Sauder; Greg Hajcak; Mike Angstadt; K Luan Phan
Journal:  Psychophysiology       Date:  2013-10-16       Impact factor: 4.016

Review 4.  Impact of ketamine on neuronal network dynamics: translational modeling of schizophrenia-relevant deficits.

Authors:  Bernat Kocsis; Ritchie E Brown; Robert W McCarley; Mihaly Hajos
Journal:  CNS Neurosci Ther       Date:  2013-04-24       Impact factor: 5.243

5.  L-methionine decreases dendritic spine density in mouse frontal cortex.

Authors:  Patricia Tueting; John M Davis; Marin Veldic; Fabio Pibiri; Bashkim Kadriu; Alessandro Guidotti; Erminio Costa
Journal:  Neuroreport       Date:  2010-06-02       Impact factor: 1.837

6.  Decreased GAD65 mRNA levels in select subpopulations of neurons in the cerebellar dentate nuclei in autism: an in situ hybridization study.

Authors:  Jane Yip; Jean Jacques Soghomonian; Gene J Blatt
Journal:  Autism Res       Date:  2009-02       Impact factor: 5.216

7.  Brain lipid concentrations in bipolar disorder.

Authors:  Miki Igarashi; Kaizong Ma; Fei Gao; Hyung-Wook Kim; Deanna Greenstein; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2009-09-19       Impact factor: 4.791

8.  Relationships between auditory event-related potentials and mood state, medication, and comorbid psychiatric illness in patients with bipolar disorder.

Authors:  Daniel J Fridberg; William P Hetrick; Colleen A Brenner; Anantha Shekhar; Ashley N Steffen; Frederick W Malloy; Brian F O'Donnell
Journal:  Bipolar Disord       Date:  2009-12       Impact factor: 6.744

9.  Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.

Authors:  Jagadeesh S Rao; Stanley I Rapoport; Hyung-Wook Kim
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 5.176

10.  Neurophyisological and neurocognitive endophenotypes for schizophrenia genetics research.

Authors:  Yeon Ho Joo
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.